Combating Antimicrobial Resistance: Aligning Policy, Advocacy, and Scientific Innovation

Antimicrobial resistance (AMR) is a growing global health crisis that threatens human, animal, and environmental health. AMR results in higher rates of illness and death, as infections become increasingly difficult to manage, and it is projected to surpass cancer as the leading cause of death by 2050, underscoring the critical importance of addressing this issue across local, state, and global levels. In this paper we will discuss:

• The interplay between policy, advocacy, and scientific advancements in combating AMR.
• The role of diagnostics in identifying and controlling antimicrobial resistance.
• The impact of patient advocacy on policy-making and healthcare outcomes.
• Successful case studies of policy changes influenced by patient stories and scientific data.
• Cross-functional collaboration as a catalyst for effective AMR strategies